title: Cell growth arrest by nucleotides, nucleosides and bases as a tool for improved production of recombinant proteins.
abstract: Arresting cell growth and thus decreasing cell division potentially lessens the chance for genetic drift in the cell population; this would be of utmost importance for the consistent production of biopharmaceuticals during long periods. The drawback of the addition of well-known synchronizing agents, such as chemotherapeutics, is that they cause a disproportionate accumulation of cellular constituents, leading to cell death. The use of compounds that are naturally synthesized by the cell, as is the case of nucleotides, nucleosides, and bases (Nt/Ns/B), is shown in this work to be a promising tool. The addition of purines and pyrimidines was tested using a CHO cell line producing the secreted form of the human placental alkaline phosphatase enzyme (SEAP). From the chemical alternatives tested, AMP was the most promising compound for protein production improvement; it reduced cell growth and maintained the culture with high cell viability for long periods, while increasing SEAP specific productivity 3-fold. The use of CHO and BHK mammalian cells producing Factor VII and the use of a insect cell line (Sf9) showed that the effect of AMP addition seems to be independent of the r-protein and cell line. With the addition of AMP, accumulation of cells at the S phase was accompanied by an increase of the protein specific productivity. Addition of known synchronizing drugs (aphidicolin and doxorubicin) and application of environmental cell growth arrest strategies (depletion of nutrients and byproduct accumulation) showed also to effectively arrest CHO cell growth. A careful look onto cell cycle distribution in the different scenarios created, shows whether it is important to consider r-protein expression dependency upon cell cycle in process optimization and operation strategies.
authors.affiliation: Instituto de Biologia Experimental e Tecnológica/Instituto de Tecnologia Química e Biológica IBET/ITQB, Apartado 12, P-2781-901 Oeiras, Portugal.
authors.forename: Ana V
authors.initials: AV
authors.lastname: Carvalhal
authors.forename: Sónia Sá
authors.initials: SS
authors.lastname: Santos
authors.forename: José
authors.initials: J
authors.lastname: Calado
authors.forename: Matthias
authors.initials: M
authors.lastname: Haury
authors.forename: Manuel J T
authors.initials: MJ
authors.lastname: Carrondo
mesh_terms: D000469:Alkaline Phosphatase / Q000096:biosynthesis*; D000818:Animals; D016466:CHO Cells / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D018929:Cell Culture Techniques / Q000379:methods; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D003067:Coenzymes / Q000494:pharmacology; D006224:Cricetinae; D006801:Humans; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D011786:Quality Control; D011994:Recombinant Proteins / Q000096:biosynthesis; D012680:Sensitivity and Specificity
chemical_list: D003067:Coenzymes; D009705:Nucleosides; D009711:Nucleotides; D011687:Purines; D011743:Pyrimidines; D011994:Recombinant Proteins; D000469:Alkaline Phosphatase